Beyond The Pap Smear Test: Enhanced Screening Of Cervical Cancer In Women ≥30 – MOC Section 1
$0
gratuit
Women's Health, Oncology
1 Credits
Description du cours
Détails du cours
Date d'expiration : 2019-03-06
Métiers: Médecin
Faculté
Mona Kamel (MD, BCh, FRCPC), Pravinsagar Mehta (MD, CCFP, FCFP), Jeff Habert (MD, CCFP, FCFP), Daniel Ngui (BSc, PT, MD, FCFP)
Accréditation
Objectif(s) d'apprentissage
Upon completion of this program, participants will be able to:
- Identify the characteristics and predictors of cervical cancer.
- Identify available screening tests, including cytology testing (Pap smear test), liquid-based cytology testing (LBC), and Cotesting (Pap/HPV).
- Identify the importance of screening and HPV testing for cervical cancer in women ≥30 years of age at high-risk for the HPV (Human Papillomavirus).
- Acknowledge current guidelines regarding HPV testing for cervical cancer in women ≥30 years of age.
- Recommend HPV tests to triage women ≥30 years of age for cervical cancer.